The store will not work correctly when cookies are disabled.
4-Amino-N'-[2-oxo-1,2-diphenylethylidene]butanehydrazide
ID: ALA2283209
PubChem CID: 76323668
Max Phase: Preclinical
Molecular Formula: C18H19N3O2
Molecular Weight: 309.37
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: NCCCC(=O)N/N=C(/C(=O)c1ccccc1)c1ccccc1
Standard InChI: InChI=1S/C18H19N3O2/c19-13-7-12-16(22)20-21-17(14-8-3-1-4-9-14)18(23)15-10-5-2-6-11-15/h1-6,8-11H,7,12-13,19H2,(H,20,22)/b21-17+
Standard InChI Key: GLWZOBONOIPNJV-HEHNFIMWSA-N
Molfile:
RDKit 2D
23 24 0 0 0 0 0 0 0 0999 V2000
2.5781 -11.9704 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.1635 -12.6869 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.3384 -12.6869 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.9281 -13.3991 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.1635 -11.2581 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.4031 -11.9704 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.8135 -12.6869 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.6385 -12.6869 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.0531 -13.3991 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.8782 -13.3991 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.2886 -12.6869 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.1136 -12.6869 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.5282 -13.3991 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.1136 -14.1156 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.2886 -14.1156 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.0531 -11.9704 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.6385 -11.2581 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.0531 -10.5459 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.8782 -10.5459 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.2886 -11.2581 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.8782 -11.9704 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.1030 -13.3991 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.6391 -14.1145 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
3 4 1 0
6 7 1 0
1 5 2 0
1 6 1 0
8 9 1 0
10 11 1 0
11 12 2 0
12 13 1 0
13 14 2 0
14 15 1 0
10 15 2 0
9 10 1 0
16 17 1 0
17 18 2 0
18 19 1 0
19 20 2 0
20 21 1 0
16 21 2 0
8 16 1 0
7 8 2 0
4 22 1 0
9 23 2 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 309.37 | Molecular Weight (Monoisotopic): 309.1477 | AlogP: 2.13 | #Rotatable Bonds: 7 |
Polar Surface Area: 84.55 | Molecular Species: BASE | HBA: 4 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 11.61 | CX Basic pKa: 9.78 | CX LogP: 2.16 | CX LogD: -0.03 |
Aromatic Rings: 2 | Heavy Atoms: 23 | QED Weighted: 0.47 | Np Likeness Score: -0.59 |
References
1. Bansal SK, Sinha BN, Khosa RL. (2013) -Amino butyric acid analogs as novel potent GABA-AT inhibitors: molecular docking, synthesis, and biological evaluation, 22 (1): [10.1007/s00044-012-0023-0] |